Table 1.
JBI Critical Appraisal Checklist for Randomized Controlled Trials* | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Studies/Total Score | Was true Randomization Used for Assignment of Participants to Treatment Groups? | Was Allocation to Treatment Groups Concealed? | Were Treatment Groups Similar at the Baseline? | Were Participants Blind to Treatment Assignment? | Were those Delivering Treatment Blind to Treatment Assignment? | Were Outcomes Assessors Blind to Treatment Assignment? | Were Treatment Groups Treated Identically Other Than the Intervention of Interest? | Was follow up Complete and if Not, were Differences Between Groups in Terms of their Follow up Adequately Described and Analyzed? | Were Participants Analyzed in the Groups to Which They were Randomized? | Were Outcomes Measured in the Same Way for Treatment Groups? | Were Outcomes Measured in a Reliable Way? | Was Appropriate Statistical Analysis Used? | Was the Trial Design Appropriate, and Any Deviations From the Standard Rct Design (Individual Randomization, Parallel Groups) Accounted for in the Conduct and Analysis of the Trial? |
Sugama et al (2012)/(10/13)24 | Y | Y | Y | Y | U | U | U | Y | Y | Y | Y | Y | Y |
Kon et al (2017)/(9/13)25 | Y | Y | N | N | N | Y | Y | Y | Y | Y | Y | Y | U |
Notes: *Checklist reproduced from: Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Chapter 3: Systematic reviews of effectiveness. In: Aromataris E, Munn Z, editors. JBI Manual for Evidence Synthesis. JBI; 2020. Available from: https://synthesismanual.jbi.global20.
Abbreviations: Y, yes; N, no; U, unclear.